DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories Limited
02 1Neuland Laboratories Limited
03 1Teva API India Private Ltd
04 2Aurobindo Pharma Limited
05 1Dasami Lab Private Limited
06 3Glenmark Life Sciences Limited
07 1HETERO LABS LIMITED
08 1Hetero Labs Limited
09 1MSD International GmbH (Singapore Branch)
10 1MSN Laboratories Private Limited
11 1MYLAN LABORATORIES LIMITED
12 2Nantong Chanyoo Pharmatech Co., Ltd
13 1Symed Labs Limited
14 1Synthimed Labs Private Limited
01 3EZETIMIBE
02 15Ezetimibe
01 2China
02 13India
03 1Israel
04 2U.S.A
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-079
Start Marketing Date : 2014-11-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (2kg/2kg)
Marketing Category : BULK INGREDIENT
Neuland Laboratories- A dedicated 100% API provider.
NDC Package Code : 58032-2004
Start Marketing Date : 2017-12-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
NDC Package Code : 15894-0011
Start Marketing Date : 2017-11-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-056
Start Marketing Date : 2024-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-698
Start Marketing Date : 2024-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66039-839
Start Marketing Date : 2006-08-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14501-0008
Start Marketing Date : 2010-03-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66022-0212
Start Marketing Date : 2023-12-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65096-0113
Start Marketing Date : 2010-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-812
Start Marketing Date : 2015-01-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Ezetimibe manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ezetimibe, including repackagers and relabelers. The FDA regulates Ezetimibe manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ezetimibe API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ezetimibe manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ezetimibe supplier is an individual or a company that provides Ezetimibe active pharmaceutical ingredient (API) or Ezetimibe finished formulations upon request. The Ezetimibe suppliers may include Ezetimibe API manufacturers, exporters, distributors and traders.
click here to find a list of Ezetimibe suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ezetimibe as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ezetimibe API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ezetimibe as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ezetimibe and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ezetimibe NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ezetimibe suppliers with NDC on PharmaCompass.
We have 13 companies offering Ezetimibe
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
